Qilian International Hold... (QLI)
5.41
-0.20 (-3.57%)
At close: Aug 09, 2024, 8:00 PM
-3.57% (1D)
| Bid | n/a |
| Market Cap | 38.68M |
| Revenue (ttm) | 93.82M |
| Net Income (ttm) | -6.54M |
| EPS (ttm) | -1.1 |
| PE Ratio (ttm) | -4.918181818181818 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 330 |
| Avg. Volume (20D) | 22,517 |
| Open | 5.41 |
| Previous Close | 5.61 |
| Day's Range | 5.41 - 5.41 |
| 52-Week Range | 1.78 - 6.69 |
| Beta | 1.41 |
About QLI
Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilia...
Sector Healthcare
IPO Date Jan 12, 2021
Employees 298
Stock Exchange NASDAQ
Ticker Symbol QLI
Website https://www.qlsyy.net
9 months ago
+29.51%
Qilian International shares are trading higher aft...
Unlock content with
Pro Subscription